Shares of Synairgen plc (LON:SNG – Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 5.20 ($0.07) and traded as low as GBX 3.60 ($0.05). Synairgen shares last traded at GBX 3.67 ($0.05), with a volume of 113,047 shares changing hands.
Synairgen Price Performance
The company has a debt-to-equity ratio of 0.09, a current ratio of 6.77 and a quick ratio of 6.35. The stock has a fifty day simple moving average of GBX 4.02 and a 200-day simple moving average of GBX 5.20. The company has a market capitalization of £7.55 million, a price-to-earnings ratio of -93.75 and a beta of -2.23.
About Synairgen
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.
Featured Articles
- Five stocks we like better than Synairgen
- The Role Economic Reports Play in a Successful Investment Strategy
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- What is the FTSE 100 index?
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- Short Selling: How to Short a Stock
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.
